360 digital solutions powered by AI to fight Antimicrobial Resistance

Leveraging lessons learnt from COVID-19 response to tackle the silent pandemic of AntiMicrobial Resistance (AMR)

It’s time
to talk about
AMR

Fighting AMR through innovative digital tools and citizens engagement

A consortium of 8 public and 5 private Swiss institutions are joining forces to fight antimicrobial resistance (AMR) silent pandemic with SPEARHEAD ‘Swiss Pandemic & AmR Health Economy Awareness Detect’ a unique multi-disciplinary research-based digital solution & patient-centric approach, addressing stewardship and prevention.

Learn more
Flagship supported by Innosuisse
University of Basel logotype
Spearhead is initiated Innovation Office, University of Basel

Our
Mission

Spearhead aims to tackle the silent pandemic of antimicrobial resistance by developing innovative multidisciplinary research-based digital solutions that addresses stewardship and prevention.
A fact:

4.95 million deaths associated with bacterial resistance in 2019

Patient
The Lancet, Jan 2022
www.thelancet.com
Learn more

Our
goals

Spearhead will leverage big data, machine learning, rapid diagnostics and digital media to help doctors make quick and effective treatment choices, and patients and citizens to become more confident in the usage of antibiotics.

The project has five main goals

1
Real-time data flow to and from decision-makers
2
Utilise rapid diagnostics to identify the right treatment at the right time
3
Leverage big data and artificial intelligence for risk prediction and improve efficacy of antibiotics
4
Early attention to the financial implications of the proposed innovations
5
Empower citizens with knowledge and awareness to make medications more effective
Learn more

OUR
SOLUTIONS

Spearhead is working to slow down antibiotic resistance through the development of a novel risk prediction
model and rapid diagnostics for doctors that allow for personalized care, while also engaging patients  and citizens for better treatment outcomes.

Spearhead aims to equip:

Doctor

Doctors

  • A risk predictive model coupled with real-time surveillance to allow data-driven decision making
    in treating infections;
  • And rapid diagnostics that can leapfrog a centralised laboratory infrastructure.
Patient

patients and citizens

  • More information and knowledge about antibiotic usage and resistance through more engaging channels such as social media and innovative digital formats.
Piggybank

healthcare
budget-holders

  • A cost-effective model solution to tackle AMR
Learn more

Final Conference

Held on 17 November 2025, the SPEARHEAD Final Event marked the conclusion of a four-year journey of collaboration to combat antimicrobial resistance. The conference showcased key results, lessons learned, and practical solutions developed across research, healthcare, industry, and policy. Together, these insights form a blueprint for future initiatives tackling AMR.

Who
we
are

Spearhead is a consortium of 13 Swiss-based partners from academics and industry, with multidisciplinary expertise across research in infectious diseases and microbiology, pharmaceuticals, med tech, machine learning and artificial intelligence, innovative design and digital communications.

map with Partners
Our Partners

Makeaware

Using stories and data sharing to empower people in the fight against antimicrobial resistance.

Data pills and workshops to raise awareness on antibiotic consumption and AMR with data

GET the power!